Related Experiment Video
Updated: Nov 25, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.7K
Shaping a data-driven era in dementia care pathway through computational neurology approaches
KongFatt Wong-Lin1, Paula L McClean2, Niamh McCombe3
1Intelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Magee Campus, Londonderry, Northern Ireland, UK. k.wong-lin@ulster.ac.uk.
BMC Medicine
|December 16, 2020
Summary
Computational approaches can enhance dementia research and care by improving diagnostic accuracy and efficiency. This data-driven strategy aims to standardize assessments and personalize patient services for better outcomes.
Area of Science:
- Computational Neurology
- Neurodegenerative Diseases
- Healthcare Informatics
Background:
- Dementia, stemming from neurodegenerative diseases, causes cognitive decline and significant socioeconomic burden.
- Complexity of dementia and comorbidities challenges research, care, and clinical decision-making.
- Current dementia care pathways are suboptimal, necessitating improved diagnostic and prognostic strategies.
Purpose of the Study:
- To propose computational approaches for advancing dementia research and clinical practice.
- To enhance the understanding of dementia aetiology and standardize assessments.
- To develop objective, efficient dementia assessments and clinical decision support systems.
Main Methods:
- Utilizing data-driven computational neurology approaches.
- Establishing appropriate data infrastructure for dementia research.
- Developing practical clinical decision support systems.
Main Results:
- Computational methods offer potential for more standardized, objective, and efficient dementia assessments.
- Improved understanding of dementia aetiology through data-driven insights.
- Addressing technical, structural, economic, political, and policy challenges for implementation.
Conclusions:
- The data-driven era in dementia research is poised to revolutionize healthcare.
- Potential for a more efficient, transparent, and personalized dementia care system.
- Computational approaches are key to transforming dementia diagnosis, prognosis, and treatment.
Related Concept Videos
Alzheimer's Disease: Treatment
592
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
592
Dementia
375
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
375
Alzheimer's Disease: Overview
1.2K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.2K

